Lysulin for Blood Sugar Management is Now Available at 750 CVS Stores
Industry: Health & Fitness
Dietary Supplement Targets Healthy Blood Glucose Levels
Boca Raton, FL (PRUnderground) November 4th, 2022
More than 750 CVS stores now carry Lysulin, a dietary supplement that helps maintain healthy blood sugar levels.
“We are honored that CVS, an industry leader, carries Lysulin, which published clinical studies show helps maintain healthy blood glucose levels, A1C’s three-month average, and insulin function,” said John Burd, CEO of Lysulin, Inc., a health and wellness company in San Diego. “We have a new product, which has been clinically tested, that may be able to help millions of people in the U.S.”
Lysulin is coming on the market just as millions of adults and children face blood sugar challenges in the U.S.
“To provide blood sugar support, we developed a dietary supplement that contains three key ingredients: Lysine, Zinc, and Vitamin C,” he said. “Research indicates that Lysine and Vitamin C help maintain healthy blood sugar levels. The nutrition you get from Zinc helps support insulin function.”
Burd, a Ph.D. scientist and biochemist, said high blood sugar levels increase the risks to the kidneys, eyes, neuropathy, and joint conditions.
“While a proper diet can help you maintain healthy blood sugar levels, more consumers today are also searching for alternative remedies,” Burd said. “Lysulin is a patented cost-effective dietary supplement without a prescription or side effects.”
Lysulin products include:
- Lysulin Capsules
- Lysulin Chewable tablets
- Lysulin Powder
- Lysulin Liquid
- Lysulin Shake in Chocolate and Vanilla flavors
Burd said he is working to add more retail outlets in the coming months.
“We just met with buyers from major retail chains in the U.S.,” Burd said. “We are now following up with each of them.”
To find Lysulin at a CVS store, click here, or purchase online at OneLavi.com.
Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. This press release is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please check with your doctor. The news site hosting this press release is not associated with Lysulin, Inc. It is merely publishing a press release announcement submitted by a company, without any stated or implied endorsement of the product or service.
About Lysulin, Inc.
Lysulin was founded by Dr. John Burd, a renowned scientist and the founder and former CEO of Dexcom, Inc., the leader in Continuous Glucose Monitoring Systems. His current research is focused on the toxic sugar coating that happens when excess glucose binds to and changes proteins in our bloodstream, a process called “protein glycation.”
